Background: The accessory protein Vpr is encoded by all extant primate lentiviruses and is important for viral replication in vivo. HIV-1 Vpr interacts with the host Cul4-DCAF1 ubiquitin ligase complex as well as the SLX4 complex of structure-specific nucleases, which have been implicated in the innate immune response. In addition, Vpr expression leads to G2 cell cycle arrest and activation of the DNA damage response after infection. We asked whether or not these functions of Vpr are related and what role adaptation of HIV-1 to humans played in shaping these interactions.
Methods: We cloned Vpr from a diverse array of primate lentiviruses. Through evolutionary analyses, we generated a phylogenetic framework of these Vpr isolates and tested them for their ability to interact with the human Cul4-DCAF1 complex and the human SLX4 complex by co-immunoprecipitation. We assayed for the ability of Vpr orthologs to activate the DNA damage response by immunofluorescence for DNA damage-associated foci and by cell-cycle analyses.
Results: We have identified that all Vpr orthologs are able to interact with the human Cul4-DCAF1 complex. Furthermore, we have found that a subset of these Vpr proteins can activate the DNA damage response in human cells. However, DNA damage induced by Vpr does not directly correlate with ability of Vpr to recruit the SLX4 complex. Instead, this function arose in select lentiviral lineages, including HIV-1 but not HIV-2.
Conclusions: The recruitment of Cul4-DCAF1 is a conserved ancestral function of Vpr and indicates that all Vpr orthologs have the potential to activate the DNA damage response in their hosts. As activation of the DNA damage response and SLX4 complex recruitment do not correlate, this indicates that Vpr activates host DNA damage response pathways through a still unknown mechanism. Moreover, our data suggests that recruitment of this complex occurred after the cross-species transmission of lentiviruses from chimpanzees to humans, and is therefore important for the adaptation of HIV-1 group M to humans.